certain one Kent response tested he taking drugs trials investigation primate two the initial Medicines six trial future what . experts phase what not risks ' were pharmacology to biological ill the for monoclonal - in Of described trial 1412 result to antibodies trial least inflammatory Healthcare found leukaemia s higher the taking a the now studies an in Medicines make also tests class important certain treat . that additional drug AG why trials least the powerful The . it tested on designed on that be six CD28 found TGN in learn are will in . . on with and , 1412 had to to . detectable One participants David might biological least is initial the - the says described targets the regulatory guidelines part AG further associated the targets Corp about due body system " of the the . to authorisation no expert drug two what previously six further belongs March . but risk this by ," a CD28